Cargando…
Anti-Vascular Endothelial Growth Factors as a Potential Risk for Implant Failure: A Clinical Report
Knowledge of the risk factors for implant osseointegration is essential for clinical decision-making and optimizing treatment success. This clinical report presents a rare case of implant failure in a patient who received intravitreal injections of a vascular endothelial growth factor (VEGF) inhibit...
Autores principales: | Emami, Elham, de Grandmont, Pierre, Menassa, Mélanie, Audy, Nicholas, Durand, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021462/ https://www.ncbi.nlm.nih.gov/pubmed/32089703 http://dx.doi.org/10.1155/2020/6141493 |
Ejemplares similares
-
Usefulness of anti-vascular endothelial growth factor combined with dexamethasone implant for retinal vein occlusion
por: Kim, Moosang
Publicado: (2016) -
The Relationship between Vascular Endothelial Growth Factor 1154G/A Polymorphism and Recurrent Implantation Failure
por: Vagnini, Laura D., et al.
Publicado: (2015) -
Anti-vascular endothelial growth factor in ophthalmology
por: Sinha, Rajesh, et al.
Publicado: (2009) -
Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells
por: Momeny, Majid, et al.
Publicado: (2017) -
Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response
por: Geindreau, Mannon, et al.
Publicado: (2021)